References
- ChiorazziNRaiKRFerrariniMChronic lymphocytic leukemiaN Engl J Med2005352880481515728813
- HamblinTChronic lymphocytic leukaemia: one disease or two?Ann Hematol200281629930312107557
- KhorasanizadehSThe nucleosome: from genomic organization to genomic regulationCell2004116225927214744436
- JenuweinTAllisCDTranslating the histone codeScience200129355321074108011498575
- BergerSLHistone modifications in transcriptional regulationCurr Opin Genet Dev200212214214811893486
- HallekMChesonBDCatovskyDGuidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesBlood2008111125446545618216293
- AronJLParthunMRMarcucciGDepsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP proteinBlood2003102265265812649137
- LiuTLiuPYMarshallGMThe critical role of the class III histone deacetylase SIRT1 in cancerCancer Res20096951702170519244112
- BrooksCLGuWHow does SIRT1 affect metabolism, senescence and cancer?Nat Rev Cancer20099212312819132007
- SimonJALangeCARoles of the EZH2 histone methyltransferase in cancer epigeneticsMutat Res20086471–2212918723033
- ChangCJHungMCThe role of EZH2 in tumour progressionBr J Cancer2012106224324722187039
- SasakiDImaizumiYHasegawaHOverexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapyHaematologica201196571271921228036
- ChenJLiJHanQEnhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemiaExp Biol Med2012237911101116
- TanakaSMiyagiSSashidaGEzh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemiaBlood201212051107111722677129
- YanJNgSBTayJLEZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activityBlood2013121224512452023529930
- PapakonstantinouNNtoufaSChartomatsidouEKottaKAgathangelidisAGiassafakiLThe histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemiaOncotarget2016724359463595927191993
- Rabello DdoALucena-AraujoARAlves-SilvaJCOverexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemiaBlood Cells Mol Dis20155419710225131810
- JankowskaAMMakishimaHTiuRVMutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3ABlood2011118143932394121828135
- PapakonstantinouNNtoufaSChartomatsidouEDifferential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemiaMol Med20131911512323615967